| Source of record | UK Clinical Trials Gateway |
| ISRCTN | ISRCTN70666174 |
| Date ISRCTN assigned | 23/01/2004 |
| Local reference number(s) | RRCC860F WATHALL |
| Public title | A Randomised Controlled Trial of goal setting and pacing for cardiac patients not suitable for group based cardiac rehabilitation |
| Scientific title |
|
| Acronym | N/A |
| Disease/condition/study domain | Cardiovascular diseases: Heart disease |
| Study hypothesis | A Randomised Control Trial of goal setting and pacing for cardiac patients not suitable for group based cardiac rehabilitation. |
| Design/methodology | Randomised controlled trial |
| Research ethics review | Not provided at time of registration |
| Countries of trial | United Kingdom |
| Participants - inclusion criteria | Coronary care patients |
| Participants - exclusion criteria | Patients who would normally be offered rehabilitation classes |
| Patient information material |
|
| Anticipated start date | 08/01/2000 |
| Anticipated end date | 03/01/2003 |
| Status of trial | Completed |
| Target number of participants | Not provided at time of registration |
| Interventions | i. Goal-setting and pacing
ii. Standard care
iii. Attention control procedure |
| Primary outcome measure(s) | The primary outcome will be an increase in fitness measured in (METS) using a standardised exercise test. The patients will also keep an activity diary. Other variables to be measured will include anxiety and depression (Hospital Anxiety and Depression Scale), health beliefs (Illness Perception Questionnaire) this questionnaire has been shown to predict a number of aspects of recovery in post MI patients, medical co morbidity the number of acute events (inc, hospital admissions), the number of consultations for cardiac reasons, risk factor profile a cumulative secondary prevention score (using method of ASPIRE group), systolic and diastolic blood pressure at rest and following exercise and the EuroQU0L, a measure of health related quality of life. All of these measures have been validated for use in this patient group and will be piloted during Phase 1 for suitability when other measures may be added. |
| Secondary outcome measure(s) | Not provided at time of registration |
| Sources of funding | NHS Executive Northern and Yorkshire |
| Sponsor name | NHS R&D Regional Programme Register - Department of Health (UK) |
| Sponsor details | The Department of Health
Richmond House
79 Whitehall
London
United Kingdom
SW1A 2NL |
| Sponsor telephone | +44 (0)20 7307 2622 |
| Sponsor fax | +44 (0)20 7307 2623 |
| Sponsor email | dhmail@doh.gsi.org.uk |
| Sponsor website | http://www.doh.gov.uk |
| Contact name | Mr P B Wathall |
| Contact details | 94 Huntington Road
York
United Kingdom
YO31 8RP |
| Contact telephone | +44 01904 640246 |
| Contact fax | +44 |
| More information | For more up-to-date information please go to the ISRCTN link below. |
| Link to record in ISRCTN Register | ISRCTN70666174 |
| Date last extracted from ISRCTN register | 17/04/2008 |
